HOW TRANSPARENT IS NH? FOLLOW OUR SCORECARD

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

601.75 -1.14 (-0.19%)
Delayed Quote Updated: 3:26 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
1 Momentum Stock Worth Investigating and 2 Facing Headwinds
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
News headline image
3 Market-Beating Stocks with Promising Prospects
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ... 
Via StockStory
Topics Energy
News headline image
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
From Medpace Holdings, Inc.
Via Business Wire
News headline image
1 Volatile Stock with Solid Fundamentals and 2 Facing Challenges
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability ... 
Via StockStory
Topics Supply Chain
Medpace Holdings (NASDAQ:MEDP) Jumps 17% After Q2 Earnings Beat and Raised Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years ↗
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a market... 
Via Benzinga
News headline image
2 Healthcare Stocks with Competitive Advantages and 1 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory
News headline image
Innventure Announces Board Leadership Changes to Further Enhance Board Independence and Acceleration of CEO Transition
From Innventure, Inc.
Via GlobeNewswire
News headline image
Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings?
Medpace currently trades at $610.21 and has been a dream stock for shareholders. It’s returned 238% since August 2021, more than tripling the S&P 500’s 70.1%... 
Via StockStory
Topics Stocks
News headline image
If You Invested $1000 In Medpace Holdings Stock 10 Years Ago, You Would Have This Much Today ↗
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an annualized basis producing an average annual return of 36.28%. Currently, Medpace Holdings has a market... 
Via Benzinga
News headline image
What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock ↗
Troendle retains a $3.27 billion combined stake, representing 19% of the market cap, with the majority of holdings controlled through Medpace Investors, LLC. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today ↗
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 26.38%. Currently, Medpace Holdings has a market... 
Via Benzinga
News headline image
Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
Via StockStory
News headline image
2 Mid-Cap Stocks Worth Your Attention and 1 We Question
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
3 High-Flying Stocks with Solid Fundamentals
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta... 
Via StockStory
News headline image
3 Cash-Heavy Stocks on Our Watchlist
Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a w... 
Via StockStory
News headline image
2 Momentum Stocks with Exciting Potential and 1 We Question
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a... 
Via StockStory
News headline image
Why Is Medpace (MEDP) Stock Soaring Today
What Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) jumped 14.4% in the afternoon session after the company reported second-qua... 
Via StockStory
News headline image
Medpace Q2 Earnings Call Highlights ↗
Medpace (NASDAQ:MEDP) reported double-digit growth in second-quarter revenue and earnings, while management described the business environment as strong and said lower cancellations helped drive record... 
Via MarketBeat
Topics Earnings
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Medpace (NASDAQ:MEDP) Exceeds Q2 CY2026 Expectations, Stock Jumps 18.6%
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 17.2% year on year ... 
Via StockStory
News headline image
Medpace Holdings, Inc. Reports Second Quarter 2026 Results
From Medpace Holdings, Inc.
Via Business Wire
News headline image
What To Expect From Medpace’s (MEDP) Q2 Earnings
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting earnings this Wednesday after market hours. Here’s what investors should know. Med... 
Via StockStory
News headline image
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
News headline image
3 Market-Beating Stocks to Target This Week
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y... 
Via StockStory
News headline image
Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026
From Medpace Holdings, Inc.
Via Business Wire
News headline image
1 Profitable Stock to Consider Right Now and 2 We Brush Off
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article